Mouawad Nicolas J, Paulisin Joseph, Hofmeister Stephen, Thomas Matthew B
McLaren Bay Heart & Vascular, McLaren Bay Region, 1900 Columbus Avenue, 4th Floor, South Tower, Bay City, MI, 48708, USA.
J Cardiothorac Surg. 2020 Apr 19;15(1):62. doi: 10.1186/s13019-020-01101-6.
Blunt thoracic aortic injury, a life-threatening concern, remains the second most common cause of mortality among all non-penetrating traumatic injuries, second only to intracranial hemorrhage. Kinetic forces from the rapid deceleration are the impetus for the injury mechanism and are graded accordingly. Given the prevalence of trauma as a public health problem, contemporary management considerations are important.
Blunt thoracic aortic injury may be fatal if not diagnosed and treated expeditiously. Endovascular options allow safe and effective management of these dangerous injuries. This paper describes the overview of blunt thoracic aortic trauma, the epidemiology, presentation, diagnosis, and treatment options with a focus on endovascular management.
Blunt thoracic aortic injury requires a high index of suspicion based on mechanism of injury in the trauma population. Endovascular options have become the mainstay of blunt thoracic aortic injury treatment whenever feasible with satisfactory results and long-term outcomes.
钝性胸主动脉损伤是一个危及生命的问题,仍然是所有非穿透性创伤性损伤中第二常见的死亡原因,仅次于颅内出血。快速减速产生的动力是损伤机制的推动力,并据此进行分级。鉴于创伤作为一个公共卫生问题的普遍性,当代的管理考量很重要。
钝性胸主动脉损伤如果不迅速诊断和治疗可能会致命。血管内治疗方案能够安全有效地处理这些危险损伤。本文概述了钝性胸主动脉创伤、流行病学、临床表现、诊断以及治疗方案,重点是血管内治疗。
基于创伤人群的损伤机制,钝性胸主动脉损伤需要高度怀疑。只要可行,血管内治疗方案已成为钝性胸主动脉损伤治疗的主要手段,效果令人满意且具有长期预后。